This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange lost 4.43 points to 786.14 Monday. Dale Styner's halted NEX shell, Top Strike Resources Corp. (TSR), plans to acquire two companies: Canadian cannabis grower United Greeneries Holdings Ltd. and Swiss cannabidiol (CBD) pill manufacturer Satipharm AG. Both targets are subsidiaries that are being spun out of the Australian Securities Exchange-listed MMJ PhytoTech Ltd. (MMJ: $0.24 (Australian)). To acquire the two targets, Top Strike must pay MMJ PhytoTech $2.5-million cash and issue enough paper to bury the shell's investors. The shell, which has 16,431,428 shares issued, will issue 300 million shares to MMJ PhytoTech's shareholders. MMJ PhytoTech may revise these acquisition terms, such that Top Strike would need to pay less cash but issue even more shares.

United Greeneries holds a licence to produce medical marijuana at its Duncan, B.C., production facility. It is applying for a second production licence, for a facility in Lucky Lake, Sask. Satipharm makes and sells a CBD pill, marketed in Europe as a dietary supplement. It began selling the pill last year. It is now negotiating distribution deals in Australia and hopes to eventually sell the pill in Canada as well.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS